Successful Treatment of Vancomycin-Resistant Enterococci Peritonitis with Quinupristin/Dalfopristin in a Patient on Continuous Ambulatory Peritoneal Dialysis.
- Author:
Jung Im JUNG
1
;
Su Jin KIM
;
Byoung Hoon JI
;
Joon Seok OH
;
Sung Min KIM
;
Yong Hun SIN
;
Joong Kyung KIM
Author Information
1. Department of Internal Medicine, Bong Seng Memorial Hospital, Busan, Korea. kidney119@hotmail.com
- Publication Type:Case Report
- Keywords:
Vancomycin-resistant enterococcus infection;
Peritoneal dialysis, Continuous ambulatory;
Peritonitis;
Quinupristin/dalfopristintin
- MeSH:
Acetamides;
Humans;
Incidence;
Oxazolidinones;
Peritoneal Dialysis, Continuous Ambulatory;
Peritonitis;
linezolid
- From:Korean Journal of Medicine
2011;80(Suppl 2):S245-S248
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Peritonitis is one of the major complications of continuous ambulatory peritoneal dialysis (CAPD). Multidrug-resistant organisms, including vancomycin-resistant enterococci (VRE), have been reported as pathogens of CAPD-associated peritonitis. The incidence of hospital-associated infections caused by VRE has recently increased. Some drugs, such as linezolid and quinupristin/dalfopristin, have been introduced as treatments of VRE infection. However, there is limited information about the effects of VRE-associated CAPD peritonitis. We present a case of successful treatment of CAPD peritonitis caused by VRE with quinupristin/dalfopristin and include a review of the literature.
